Subcutaneous immunoglobulin replacement therapy for primary antibody deficiency: advancements into the 21st century.

@article{Moore2008SubcutaneousIR,
  title={Subcutaneous immunoglobulin replacement therapy for primary antibody deficiency: advancements into the 21st century.},
  author={Meredith L. Moore and James M. Quinn},
  journal={Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology},
  year={2008},
  volume={101 2},
  pages={114-21; quiz 122-3, 178}
}
OBJECTIVES To provide a review of the world literature and discuss the clinical role of subcutaneous immunoglobulin (SCIG) therapy for primary antibody deficiency. DATA SOURCES English-language publications on SCIG therapy were identified through MEDLINE and through the reference list of the initially identified publications. STUDY SELECTION Articles pertaining to SCIG for the treatment of immunodeficiency, particularly primary antibody deficiency, were selected. RESULTS SCIG therapy has… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 23 extracted citations

Similar Papers

Loading similar papers…